These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 6105690)
21. The clinical association of tardive dyskinesia and drug-induced parkinsonism. Wolf ME; Chevesich J; Lehrer E; Mosnaim AD Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032 [No Abstract] [Full Text] [Related]
22. Extrapyramidal side effects of antipsychotic medications. Harris E Am J Nurs; 1981 Jul; 81(7):1324-8. PubMed ID: 6113762 [No Abstract] [Full Text] [Related]
23. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms. Wilbur R; Kulik FA Prog Neuropsychopharmacol; 1980; 4(6):627-32. PubMed ID: 6111820 [No Abstract] [Full Text] [Related]
24. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344 [TBL] [Abstract][Full Text] [Related]
25. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. Lohr JB; Caligiuri MP J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552 [TBL] [Abstract][Full Text] [Related]
26. Tardive dyskinesia and antiparkinsonian medication. Chouinard G; De Montigny C; Annable L Am J Psychiatry; 1979 Feb; 136(2):228-9. PubMed ID: 32778 [No Abstract] [Full Text] [Related]
32. [Main side effects of the use of neuroleptics]. Morato GS; Takahashi RN AMB Rev Assoc Med Bras; 1982; 28(11-12):247-9. PubMed ID: 6133319 [No Abstract] [Full Text] [Related]
33. [Iatrogenic extrapyramidal disorders]. Ludin HP Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812 [TBL] [Abstract][Full Text] [Related]
34. Factors related to tardive dyskinesia. Chouinard G; Annable L; Ross-Chouinard A; Nestoros JN Am J Psychiatry; 1979 Jan; 136(1):79-82. PubMed ID: 31802 [TBL] [Abstract][Full Text] [Related]
35. Propranolol in the treatment of neuroleptic-induced akathisia. Lipinski JF; Zubenko GS; Cohen BM; Barreira PJ Am J Psychiatry; 1984 Mar; 141(3):412-5. PubMed ID: 6142657 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome. Chaudhry R; Radonjic D; Waters B Am J Psychiatry; 1982 May; 139(5):674-6. PubMed ID: 6122382 [No Abstract] [Full Text] [Related]
38. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms. Bezchlibnyk-Butler KZ; Remington GJ Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605 [TBL] [Abstract][Full Text] [Related]
39. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Ganzini L; Casey DE; Hoffman WF; McCall AL Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437 [TBL] [Abstract][Full Text] [Related]
40. Tolerability of low dose neuroleptics: a case control study of flupenthixol. Fritze J; Spreda I Eur Neuropsychopharmacol; 1997 Nov; 7(4):261-6. PubMed ID: 9443657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]